Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study. - Wikidata - wikimedia - TriplyDB

Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study.

Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study.

http://www.wikidata.org/entity/Q37055493

about

PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future High-Sensitivity Troponin as a Biomarker in Heart Rhythm Disease.High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study.Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).Cardiac biomarkers in HIV-exposed uninfected children.Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage.The association between cortisol response to mental stress and high-sensitivity cardiac troponin T plasma concentration in healthy adults.Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study.Elevated cardiac markers in chronic kidney disease as a consequence of hyperphosphatemia-induced cardiac myocyte injury Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study.The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease.High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort Study.Cardiac microinjury measured by troponin T predicts collagen metabolism in adults aged >=65 years with heart failure.The association between fibrinogen reactivity to mental stress and high-sensitivity cardiac troponin T in healthy adults The mediation of coronary calcification in the association between risk scores and cardiac troponin T elevation in healthy adults: Is atherosclerosis a good prognostic precursor of coronary disease?Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing.High-Sensitivity Cardiac Troponin T and Risk of Hypertension.Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care.Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality.The Association of Socioeconomic Status With Subclinical Myocardial Damage, Incident Cardiovascular Events, and Mortality in the ARIC Study.Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general population.Antemortem Screening for Left Ventricular Hypertrophy in Rhesus Macaques (Macaca mulatta).25-Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study.Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives.High-sensitivity troponin assays in the evaluation of patients with acute chest pain in the emergency department.Lipid lowering with PCSK9 inhibitors.Sleep apnea in total joint arthroplasty patients and the role for cardiac biomarkers for risk stratification: an exploration of feasibility.Analytical and biological variability in biomarker measurement in the Hispanic Community Health Study/Study of Latinos.Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study.Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death.Physical Activity, Obesity, and Subclinical Myocardial Damage.Severity of hypoxia modulates effect of CPAP on myocardial stress as measured by highly sensitive troponin T.Variability and Error in Cardiac Troponin Testing: An ACLPS Critical Review.

P2860

Q28083595-03CB005F-5FC5-45BD-822D-A113A9C952B3 Q30235455-753421BA-F066-4783-9915-B974C74D2A1E Q30583705-6952906B-708D-445B-B812-177CDD76B3E1 Q33551467-25DCC1C2-B56F-4485-A783-DCD48DD800B0 Q34081675-4735949F-AB35-4F0B-BB59-9E8A31E8BF0F Q34345083-8C0FEA92-1BA2-4CFE-B2C3-4B626377C061 Q34354255-BC484EF5-D332-44B2-8B26-1B651A3B5D58 Q34397304-7A17A21F-7281-4BBA-A18F-FA5835EEE5C5 Q34428293-AB8F9FD7-AB21-4C41-BD67-89889590BC7F Q35102964-82455DD5-3D3A-4DD6-B2BB-C964D5E0A4BF Q35216649-464866A1-8A9E-475B-A59D-D242D8A80A14 Q35599099-EF33A069-29DA-4EB1-92E9-FB34BD096B66 Q35639702-4D5C7179-1D7D-47E8-B677-9B8EFE6CB854 Q35777180-6A41DE5D-F2F9-46AD-8655-673C7E63AF07 Q35881891-4D947458-D031-467E-A53E-FB17B3A8DBDC Q35897698-F8060E4A-769B-4C84-90EC-A8003BC6EEFD Q36007847-C979B6B1-C7EF-4D06-96C5-179DB95CCFC7 Q36021339-B87C6586-7DF3-419B-A0A5-DC0E4AB5DF94 Q36119303-4A8F068D-577E-42DB-AA9F-2450004B18E8 Q36143273-C48186C2-633C-4F4D-BF16-9FB1735F3D8F Q36527607-408112E1-E13C-43EA-9116-EB547E924176 Q36634511-09D95766-D9D2-4133-8242-F143DFA15C39 Q36957778-782B0F2F-C313-4059-A154-1621374E4B3F Q37171767-079D97D8-B85B-481B-90C3-9FD04099489D Q37556051-99E536CB-1E53-4FEC-B7AA-4862803F25D0 Q37688760-1C9709DE-D173-46C6-9725-916D12DBADBA Q37926596-4301311B-8CB8-48CA-9910-8D888B582441 Q38222649-84EFD3F7-479E-486F-95FD-03169E413B51 Q38754350-3BDE36AB-69B4-4300-BFAA-B3B39DA3E115 Q38799203-21FFC093-557C-4919-A10F-407E654BB30F Q39354235-F7644357-0A0D-4D81-9701-E5A280419DD6 Q39579918-FEAC5976-3B2E-46F5-B45D-AD961A7697BF Q40224811-63F4A231-F7B1-41DA-AD92-9E78F14F7D78 Q43215786-94549F31-0581-4004-A297-86F948B346A9 Q47716507-B3A80190-1372-45B2-915F-741881E82FA7

P2860

Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study.

http://www.wikidata.org/entity/Q37055493

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Sources of variability in meas ...... sis risk in communities study.

@en

Sources of variability in meas ...... sis risk in communities study.

@nl

type

label

Sources of variability in meas ...... sis risk in communities study.

@en

Sources of variability in meas ...... sis risk in communities study.

@nl

prefLabel

Sources of variability in meas ...... sis risk in communities study.

@en

Sources of variability in meas ...... sis risk in communities study.

@nl

P1433

Q37055493-74026995-CA2B-410E-846C-22D067B25657

P1476

Q37055493-F5913D6A-AF34-417C-9680-8DAE30548932

P2093

Q37055493-0F74FCF3-7057-4CC2-9473-63E3C6238FBF

Q37055493-20E24D4F-B35B-413F-971D-52DE2BF70E9E

Q37055493-301837C8-04DA-43DE-866B-334536CA84F0

Q37055493-7182070F-E5C7-4491-8BA2-9BCC8AC8ACFA

Q37055493-97E1AF3C-0DA2-4EDC-96F9-2FDF89B27FE3

Q37055493-D24565DB-A329-49BE-BC57-F355A8A66F66

Q37055493-D531EAD7-5B8A-4DB4-861F-FAD37CE74FF8

Q37055493-ED9C678B-4195-4059-B641-826B00B2F1A9

P2860

Q37055493-29397D2B-0ECE-47C2-A572-16EFD63FC5F4

Q37055493-2DBA97D3-464E-468A-9B7B-952DD6CB017B

Q37055493-329B942C-613E-4216-A6D6-6F6D2E8D166D

Q37055493-3E1EE0B6-78DD-4D15-B268-10173B211954

Q37055493-48EDC4BF-2A67-4B7E-B4BF-B4F8B5CCACDE

Q37055493-4DB9B102-B687-4343-8241-97DE32553A73

Q37055493-50565183-3895-4FAF-8BC1-A4B02472E740

Q37055493-67A05491-61EE-4F5C-9C3C-04DD50A06FF2

Q37055493-7A3CF8B0-9381-4603-88DD-E7FD7E5BC801

Q37055493-7F7EE552-46E5-436B-90BD-AACF0B4D873D

P304

Q37055493-F8448011-EF8C-4EDA-A4F9-4002A7B09BC9

P31

Q37055493-C1B3DE57-838A-4C5F-974E-34343CEFFE60

P356

Q37055493-1A3A35EF-DE3A-407D-B3A9-CA4AE513C1DF

P407

Q37055493-DA2A2F69-AF49-4485-8B2D-CB7713312718

P433

Q37055493-1214DAB2-38D8-41CE-A17E-C161CC8D4B5D

P478

Q37055493-44864BE0-F234-46C7-9BC7-2C3750825D11

P50

Q37055493-474D0A2D-E9A6-4CBC-90D4-0DB7A186F2F0

Q37055493-CD465B0A-8717-46C4-BECC-D4ADF363E971

P577

Q37055493-33DA0C99-A5C6-4B77-A199-978A1BF5D950

P5875

Q37055493-6128E30D-C876-4154-9F37-2DC856B837B0

P698

Q37055493-43C9CA07-E15D-4958-B468-492F0EC1F292

P921

Q37055493-4F4179A8-9B53-4850-A176-E347DB75FD55

P932

Q37055493-A7F4FA7A-2D96-4C57-85E7-0D4785D98954

P356

CLINCHEM.2010.159350

P1433

Clinical Chemistry

P1476

Sources of variability in meas ...... sis risk in communities study.

@en

P2093

A Richey Sharrett

http://www.w3.org/2001/XMLSchema#string

Christie M Ballantyne

http://www.w3.org/2001/XMLSchema#string

Christy L Avery

http://www.w3.org/2001/XMLSchema#string

Diane Catellier

http://www.w3.org/2001/XMLSchema#string

Justin Saunders

http://www.w3.org/2001/XMLSchema#string

Ron C Hoogeveen

http://www.w3.org/2001/XMLSchema#string

Sunil K Agarwal

http://www.w3.org/2001/XMLSchema#string

Vijay Nambi

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical methods for assessing agreement between two methods of clinical measurement

Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction

Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Generation and application of data on biological variation in clinical chemistry.

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

Serum cardiac troponin T and plasma brain natriuretic peptide in patients with cardiac decompensation

Atherosclerosis Risk in Communities (ARIC) Carotid MRI flow cytometry study of monocyte and platelet markers: intraindividual variability and reliability.

National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases.

Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure.

P304

891-897

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1373/CLINCHEM.2010.159350

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51075989

http://www.w3.org/2001/XMLSchema#string

P698

21519038

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4928588

http://www.w3.org/2001/XMLSchema#string